Essex Bio-Technology Joins X-ZELL Seed+ Investment Round Singapore/Hong Kong, April 2020 – Rare cell detection specialist X-ZELL has entered into an investment agreement with Essex Bio-Investment, a wholly owned subsidiary of Essex Bio-Technology Ltd (“EssexBio”)....
X-ZELL featured in German life science magazine Laborjournal Freiburg, April 2020 – X-ZELL has been featured in the April edition of Laborjournal, one of Germany’s leading life science publications. The extensive company profile, penned by science journalist Dr...
Episode 15 A start-up’s guide to braving the Corona crisis The COVID-19 pandemic is not only placing unprecedented stress on the global healthcare system, but also challenging some of the most fundamental paradigms of modern business culture. Entire nations are going...
